The consolidated profit after tax for the year 2023 of Biokarpet Group amounted to €5.58 million, compared to a profit of €9.13 million in the corresponding fiscal year 2022, a decrease of 39%.

In particular, the BioΚarpet Group's net sales amounted to €209.99 million in 2023 compared to €231.22 million in the corresponding fiscal year 2022, a decrease of 9%. In particular, according to the financial results, the group's exports amounted to €108.31 million in 2023 compared to €135.68 million in the corresponding fiscal year 2022, a decrease of 20.17%.

In particular:

Exports accounted for 51.58% of total turnover. Domestic sales amounted to €101.68 million in FY 2023 compared to €95.55 million in FY 2022, an increase of 6.43%. Consolidated earnings before interest, taxes, financial and investment income, depreciation, and amortization (EBITDA), amounted to €20.04 million in FY 2023, compared to €21.88 million in FY 2022, a decrease of 8%.

The Group reported a profit before tax of €6.28 million for FY 2023 compared to €10.84 million for FY 2022, a decrease of 42%. The Group reports a consolidated profit after tax for FY 2023 of €5.58 million, compared to a profit of €9.13 million for FY 2022, a decrease of 39%.

The outlook for 2024 is optimistic for the Group's management. the completion of the transfer of the entire production process of the subsidiary Exalco to Koulouri Larissa in early April 2024 is expected to bring significant economies of scale and significantly help the Group's financial performance, from the second half of 2024 and especially in the year 2025.